Early Detection of Cervical Cancer Can Start at Home

Translate to Spanish or other 102 languages!

anuary is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. Image for illustration purposes
anuary is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – January is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. 

But with early screenings, that number could go down. 

“What’s interesting about cervical cancer, unlike many cancers, cervix cancer has a very long pre-cancerous phase, which is why screening is very helpful,” said Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic. 

- Advertisement -

Dr. DeBernardo said screening for cervical cancer typically includes getting a pap smear, which can be uncomfortable for some women. 

However, there may soon be another option available. 

The FDA recently approved an at-home test kit. 

It looks for the presence of  HPV, or human papillomavirus. 

- Advertisement -

Dr. DeBernardo explains that nearly all cervical cancer cases are driven by HPV.

If the results of the test came back negative, then the person would not need to get a pap smear. 

“This test is going to be approved only for women at no elevated risk. So, for instance, if  I’ve had a problem with my pap smear in the past, no good. If I am immunosuppressed because I had a kidney transplant, no good — or HIV. There are going to be people that this test is not really designed for, and they should be seeing the gynecologist regularly,” said Dr. DeBernardo.

The  U.S. Department of Health and Human Services also updated its cervical cancer screening guidelines to include the use of the at home test kit. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -